Better Buy: Canopy Growth vs. Aphria
Ever since the end of the first quarter of 2019, pot stocks have been in a downward spiral. Underwhelming earnings, several scandals, managerial turnover, Health Canada's slow approval process for both physical retail outlets and key derivative products like vapes, enormous tax rates, the existence of a thriving black market, and of course, financing issues have all weighed on valuations across the space over the prior 10 months. This steep market correction, though, may represent a once-in-a-lifetime buying opportunity for patient investors. After all, legal cannabis is still expected to be one of the fastest growing industries in the world during the current decade, despite these early headwinds.
Which pot stocks represent the best bargains in the wake of this prolonged downturn? Within the realm of elite licensed producers, Canada's Canopy Growth Corp. (NYSE: CGC) and Aphria (NYSE: APHA) could both come to own an outsized share of the global cannabis market by the end of the decade. So, with this brief background in mind, let's check out how these two pot stocks stack up on several fronts to decipher which one is the hands-down better buy right now.
Image source: Getty Images.
Source Fool.com
